Post

@ColumbiaMed

This Thread may be Removed Anytime!

Twitter may remove this content at anytime! Save it as PDF for later use!

More from @BevTchangMD

Beverly G. Tchang, MD

@BevTchangMD

Feb 20

This is a beautiful study, answering many of the questions we clinicians and our patients are asking:

🤔What happens if I stop the GLP1?

Here's one punch line that we all could've guessed:
⭐️Exercise mitigates #weight regain when anti #obesity #medicine is stopped⭐️

But there's a lot more to observe here:

🧵1/

Here's the study method:

There's an "induction" phase 1 where #weightloss is caused by a low-calorie #diet over 8 weeks

Then everyone is randomized to 1 of these 4 groups

After 1 year, all of these interventions are stopped, and researchers just watch to see what happens to #weight

2/

Going back to this main figure, interesting things pop out:

👉We all slowly find our ways back to baseline weight regardless of #obesity treatment type
👉All groups (not just those with meds) rebounded to higher than what the weight was before the treatment phase, but greatest rebound was with liraglutide alone
👉Greatest additional weight loss was seen with combination lira+exercise

3/

Read 4 tweets

Beverly G. Tchang, MD

@BevTchangMD

May 4, 2023

Packed room with Richard J. Auchus, MD, PhD, FACE on #adrenal #hypertension

- drugs can cause false negative screens but not false positive screens
- you can probably just treat with mineralocorticoid antagonist instead of going through the diagnostic steps

#AACE2023

1/

This is such an excellent talk that I don’t have much commentary to add. Just sharing high yield slides!

2/

Read 7 tweets

Beverly G. Tchang, MD

@BevTchangMD

May 4, 2023

https://twitter.com/endojorm/status/1654224072979660800

Interesting to see anti #obesity and #diabetes #medication management from the perspective of PharmDs

I'm always pro-collaborative care!

Here are some learning points and fact checks:

#AACE2023 #endocrine #endocrinology #pharmacology

1/

https://twitter.com/endojorm/status/1654224072979660800

- "Tirzepatide is a dual agonist"
👉It ↑GIP activity but GLP-1R agonism is less than that of endogenous GLP-1
- "Hypoglycemia is not a concern if you're not on insulin"
👉Risk of hypoglycemia ~1.4% vs. 0.2% in placebo in SURMOUNT-1

nejm.org/doi/full/10.10…

2/

- "In this pt with uncontrolled #diabetes, A1c 7.4, we decreased glargine by 10% [when we started tirzepatide]"

👉 Not sure where the evidence is here, but the SURPASS-5 trial protocol reduced basal by 20% in participants with baseline A1c<8

jamanetwork.com/journals/jama/…

3/

Read 5 tweets

Beverly G. Tchang, MD

@BevTchangMD

May 4, 2023

@DrKarlNadolsky

@DrKarlNadolsky presents the overarching themes and calls to action of @TheAACE 's new #obesity guidelines:

#AACE2023
1/

@ConscienHealth

👉Reduce #WeightStigma
The bidirectional relationship between #weightbias and #obesity is unequivocal

I'm moved by the enormous consensus among multiple professional societies, MDs PhDs MPHs experts etc, on how important this is

@ConscienHealth @scottkahan
2/

👉Refocus on the Psychological Health and Social Determinants of Health

3/

Read 5 tweets

Beverly G. Tchang, MD

@BevTchangMD

May 3, 2023

@alpanashuklamd

@alpanashuklamd takes the stage at the @ColumbiaMed @WeillCornell #Obesity Conference

@alpanashuklamd

@alpanashuklamd et al examined the effect of macronutrient sequencing (carbs first vs carbs last) in ppl with diabetes, prediabetes, or gestational diabetes

This study looked at those with prediabetes:
dom-pubs.onlinelibrary.wiley.com/doi/abs/10.111…

2/

Among those with prediabetes, we saw significant differences in glucose, insulin, ghrelin, and GLP-1 -- all favoring the "carbohydrates-last" food order

3/

Read 5 tweets

Beverly G. Tchang, MD

@BevTchangMD

May 3, 2023

@KevinH_PhD

Always a pleasure to listen to @KevinH_PhD discuss his testing of hypotheses in contributors to #obesity
1/

Many people remember his 14-day study of ultra processed foods (UPF) vs unprocessed foods (n=20) that found energy intake was ~500 kcal/d LESS with unprocessed meals

cell.com/cell-metabolis…
2/

Details you might not know:
- Groups were not matched for type of sugar
- No hint of a difference in insulin sensitivity between groups based on OGTT results
- Groups were not matched for beverage amount (and implication for speed of food intake)

3/

Read 7 tweets

Share this page!

Enter URL or ID to Unroll

Beverly G. Tchang, MD

Try unrolling a thread yourself!

More from @BevTchangMD

Beverly G. Tchang, MD

Beverly G. Tchang, MD

Beverly G. Tchang, MD

Beverly G. Tchang, MD

Beverly G. Tchang, MD

Beverly G. Tchang, MD

Did Thread Reader help you today?

Don't want to be a Premium member but still want to support us?

Send Email!